SCO-1, a novel plasmid-mediated class a β-lactamase with carbenicillinase characteristics from Escherichia coli

被引：13
|
作者：
Papagiannitsis, C. C.
Loli, A.
Tzouvelekis, L. S.
Tzelepi, E.
Arlet, G.
Miriagou, V.
机构：
[1] Inst Pasteur, Bacteriol Lab, GR-11521 Athens, Greece
[2] Univ Athens, Sch Med, Dept Microbiol, GR-11521 Athens, Greece
[3] Univ Paris 06, UPRES EA 2392, UFR St Antoine, Bacteriol Lab, F-75252 Paris, France
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2007年 / 51卷 / 06期
关键词：
D O I：
10.1128/AAC.01439-06
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
A novel class A beta-lactamase (SCO-1) encoded by an 80-kb self-transferable plasmid from Escherichia coli is described. The interaction of SCO-1 with beta-lactams was similar to that of the CARB-type enzymes. Also, SCO-1 exhibited a 51% amino acid sequence identity with the RTG subgroup of chromosomal carbenicillinases (RTG-1, CARB-5, and CARB-8).
引用
收藏
页码：2185 / 2188
页数：4
相关论文
共 50 条
  • [41] IDENTIFICATION OF A NOVEL PLASMID-MEDIATED BETA-LACTAMASE WITH CHROMOSOMAL CEPHALOSPORINASE CHARACTERISTICS FROM KLEBSIELLA-PNEUMONIAE
    TZOUVELEKIS, LS
    TZELEPI, E
    MENTIS, AF
    TSAKRIS, A
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 (05) : 645 - 654
  • [42] NOVEL PLASMID-MEDIATED BETA-LACTAMASE IN MEMBERS OF THE FAMILY ENTEROBACTERIACEAE FROM OHIO
    SHLAES, DM
    MEDEIROS, AA
    KRON, MA
    CURRIEMCCUMBER, C
    PAPA, E
    VARTIAN, CV
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (02) : 220 - 224
  • [43] Plasmid-Mediated mcr-1 Colistin Resistance in Escherichia coli from a Black Kite in Russia
    Tarabai, Hassan
    Valcek, Adam
    Jamborova, Ivana
    Vazhov, Sergey V.
    Karyakin, Igor V.
    Raab, Rainer
    Literak, Ivan
    Dolejska, Monika
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (09)
  • [44] Cefotaxime for the detection of extended-spectrum β-lactamase or plasmid-mediated AmpC β-lactamase and clinical characteristics of cefotaxime-non-susceptible Escherichia coli and Klebsiella pneumoniae bacteraemia
    Matsumura, Y.
    Yamamoto, M.
    Matsushima, A.
    Nagao, M.
    Ito, Y.
    Takakura, S.
    Ichiyama, S.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (08) : 1931 - 1939
  • [45] CLONING AND SEQUENCE-ANALYSIS OF BLA(BIL-1), A PLASMID-MEDIATED CLASS-C BETA-LACTAMASE GENE IN ESCHERICHIA-COLI BS
    FOSBERRY, AP
    PAYNE, DJ
    LAWLOR, EJ
    HODGSON, JE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (05) : 1182 - 1185
  • [46] Cefotaxime for the detection of extended-spectrum β-lactamase or plasmid-mediated AmpC β-lactamase and clinical characteristics of cefotaxime-non-susceptible Escherichia coli and Klebsiella pneumoniae bacteraemia
    Y. Matsumura
    M. Yamamoto
    A. Matsushima
    M. Nagao
    Y. Ito
    S. Takakura
    S. Ichiyama
    European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 1931 - 1939
  • [47] Plasmid-mediated colistin-resistant Escherichia coli detected from 2014 in Norway
    Solheim, Margrete
    Bohlin, Jon
    Ulstad, Charlotte R.
    Slettemeas, Jannice Schau
    Naseer, Umaer
    Dahle, Ulf R.
    Wester, Astrid L.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2016, 48 (02) : 227 - 228
  • [48] Plasmid-mediated resistance to cephalosporins and quinolones in Escherichia coli from American crows in the USA
    Jamborova, Ivana
    Dolejska, Monika
    Zurek, Ludek
    Townsend, Andrea K.
    Clark, Anne B.
    Ellis, Julie C.
    Papousek, Ivo
    Cizek, Alois
    Literak, Ivan
    ENVIRONMENTAL MICROBIOLOGY, 2017, 19 (05) : 2025 - 2036
  • [49] Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan
    Yamane, Kunikazu
    Wachino, Jun-ichi
    Suzuki, Satowa
    Arakawa, Yoshichika
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (04) : 1564 - 1566
  • [50] Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China
    Wang, MG
    Tran, JH
    Jacoby, GA
    Zhang, YY
    Wang, F
    Hooper, DC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) : 2242 - 2248
12345